ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,856Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 1454

$1.14M Total Retail Price of All Prescriptions

Rank: 53 out of 1454

865 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 865 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 865 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 15,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 838 775 1 4
AMLODIPINE BESYLATE 734 684 2 2
ATORVASTATIN CALCIUM 660 581 3 11
SIMVASTATIN 547 470 4 1
OMEPRAZOLE 540 439 5 3
HYDROCODONE-ACETAMINOPHEN 533 441 S3 6 7
HYDROCHLOROTHIAZIDE 452 415 7 9
GABAPENTIN 421 334 8 16
METFORMIN HCL 411 363 9 8
FUROSEMIDE 388 328 10 6
LEVOXYL 381 348 11 84
ZOLPIDEM TARTRATE 381 339 11 19
PRAVASTATIN SODIUM 365 340 13 12
LOSARTAN POTASSIUM 334 302 14 14
METOPROLOL SUCCINATE 309 292 15 13
CRESTOR 300 292 16 22
METOPROLOL TARTRATE 288 232 17 10
LOVASTATIN 283 248 18 39
ATENOLOL 275 248 19 18
JANTOVEN 235 230 20 100
KLOR-CON 10 211 188 21 141
SERTRALINE HCL 208 198 22 26
FENOFIBRATE 169 139 23 68
DONEPEZIL HCL 155 145 24 29
NEXIUM 154 120 25 23
PANTOPRAZOLE SODIUM 150 128 26 31
FLUTICASONE PROPIONATE 145 122 27 30
CLOPIDOGREL 143 134 28 32
DILTIAZEM 24HR CD 141 138 29 76
TAMSULOSIN HCL 141 102 29 34
POTASSIUM CHLORIDE 137 126 31 15
GLYBURIDE 131 110 R 32 98
HYDRALAZINE HCL 123 115 33 67
LEVOTHYROXINE SODIUM 116 113 34 5
CARVEDILOL 115 104 35 24
POLYETHYLENE GLYCOL 3350 112 104 36 61
CLONIDINE HCL 109 104 37 49
ISOSORBIDE MONONITRATE ER 105 96 38 46
PREDNISONE 103 92 39 36
PLAVIX 102 98 40 45
VENTOLIN HFA 102 84 40 112
ZETIA 101 100 42 69
COMBIVENT 98 95 43 115
KLOR-CON M20 94 85 44 54
LOSARTAN-HYDROCHLOROTHIAZIDE 86 81 45 38
AMOXICILLIN 84 68 46 133
ZOLPIDEM TARTRATE ER 81 79 47 300
LANSOPRAZOLE 81 75 47 140
MELOXICAM 80 67 49 37
ACTOS 79 78 50 90
AZITHROMYCIN 79 69 50 42
SPIRONOLACTONE 78 64 52 63
CYCLOBENZAPRINE HCL 77 47 R 53 59
JANUVIA 75 69 54 77
DICLOFENAC SODIUM 75 62 54 118
CITALOPRAM HBR 73 44 56 21
CHLORTHALIDONE 71 71 57 109
ALLOPURINOL 69 60 58 28
CYMBALTA 69 64 58 55
CELEBREX 68 61 60 81
KLOR-CON M10 65 65 61 145
RANITIDINE HCL 64 64 62 43
ADVAIR DISKUS 64 64 62 47
TOPIRAMATE 64 46 62 192
PROPRANOLOL HCL 64 60 62 129
TRAMADOL HCL 63 39 66 20
LEVOFLOXACIN 62 54 67 95
DOXAZOSIN MESYLATE 62 51 67 87
AMITRIPTYLINE HCL 62 51 R 67 71
PEN NEEDLE 60 54 70 113
CIPROFLOXACIN HCL 60 58 70 64
NAMENDA 59 59 72 48
METHOCARBAMOL 58 54 R 73 210
NAPROXEN 56 31 74 122
DIOVAN 54 47 75 40
SYNTHROID 54 54 75 25
IBUPROFEN 53 42 77 107
INDAPAMIDE 52 51 78 184
ROPINIROLE HCL 51 35 79 96
NOVOLOG MIX 70-30 FLEXPEN 51 37 79 211
BENICAR 50 35 81 189
VERAPAMIL ER 50 44 81 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.